Dexus stock heads toward an AGM vote on CEO incentive rights

Published on 10/08/2026 at 05:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At 2:22 p.m. AEDT on October 8, 2026, Dexus traded at AUD 5.67 with a 0.80 percent gain. FY27 AFFO guidance of 37.5 to 39.5 cents trails FY26's 45.0 cents.

Dexus, AU000000DXS1, Illustration mit AI erstellt.

Dexus stock (ISIN AU000000DXS1) was trading at AUD 5.67 on the ASX on October 8, 2026, up 0.80 percent at 2:22 p.m. AEDT. The latest company event concerns a proposed grant of 527,240 performance rights to Chief Executive Officer Ross Du Vernet, valued at AUD 5.69 each.

CEO incentive vote sets the near term

According to EQS News on October 1, 2026, the grant followed the 25-trading-day volume-weighted average price calculation after Dexus released its FY26 results. Security holders will vote on the proposal at the company's annual general meeting on October 28, 2026.

The incentive proposal gives the upcoming AGM a specific financial reference point. The performance-right value of AUD 5.69 is close to the AUD 5.67 market price cited above, while the proposed award contains 527,240 rights rather than a cash payment.

FY27 guidance lowers the earnings bar

Dexus reported adjusted funds from operations of AUD 483.9 million, or 45.0 cents per security, for fiscal year 2026. According to Land.com.au on September 18, 2026, statutory net profit after tax was AUD 482.2 million and distributions were 37.0 cents per security.

For fiscal year 2027, Dexus guided to AFFO of 37.5 to 39.5 cents per security, below the 45.0 cents delivered in FY26. The same release attributed the outlook to lower performance fees, limited trading profits and a smaller contribution from funds under review, while distributions were held at 37.0 cents.

Analysts see room above AUD 5.67

According to MarketScreener on September 23, 2026, 11 analysts gave Dexus an Accumulate consensus, with an average target of AUD 6.502, a high target of AUD 8.300 and a low target of AUD 5.600. The average target lies 14.6 percent above the AUD 5.67 price.

A more cautious single-house view came from Morgan Stanley. Markets Insider reported on September 22, 2026, that Morgan Stanley maintained a Sell rating and an AUD 6.10 price target. The split between the consensus and that rating leaves FY27 cash earnings and execution at the AGM as the key valuation reference points.

Dexus stock trades above its yearly low

Dexus stock was trading at AUD 5.67 on the ASX on October 8, 2026, against a 52-week range of AUD 5.30 to AUD 7.73. Its market capitalization was AUD 6.1 billion and volume stood at 660,174 shares on the same date, giving the stock a market value above its yearly low while the FY27 guidance remains below FY26 cash earnings.